Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol. [electronic resource]
Producer: 20080716Description: 1894-904 p. digitalISSN:- 1530-6860
- Antineoplastic Agents, Phytogenic
- Apoptosis -- drug effects
- Benzamides
- Caspases
- Cell Differentiation -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm
- Humans
- Imatinib Mesylate
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Piperazines -- pharmacology
- Pyrimidines -- pharmacology
- Resveratrol
- Stilbenes -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.